tirzepatide no longer in shortage The FDA says it's standing by its earlier decision that the of — the active ingredient Eli Lilly's diabetes and weight loss drugs Mounjaro and Zepbound — is over The FDA says the Zepbound

This dual action is what sets it apart, often leading to more significant weight loss results compared to medications that only target one

A licensed healthcare provider will provide a custom dosing and treatment plan tailored to your individual needs

MRI scans were acquired using a uniform scanning protocol that minimized and accounted for between-site differences in MRI systems

The role of gender differences and menopause in obesity-related renal disease, renal inflammation and lipotoxicity

Medication selection, dosing, and monitoring are determined by licensed healthcare providers based on individual medical needs